BIOMERICA INC Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- BIOMERICA INC stock issued during period, value, stock options exercised for the quarter ending 2025-02-28 was $16.00K.
- BIOMERICA INC stock issued during period, value, stock options exercised for the quarter ending 2022-11-30 was $66.00K, a 115.79% increase year-over-year.
- BIOMERICA INC stock issued during period, value, stock options exercised for the quarter ending 2022-08-31 was $14.00K, a 259.44% increase year-over-year.
- BIOMERICA INC stock issued during period, value, stock options exercised for the quarter ending 2022-05-31 was $37.83K, a 552.16% increase year-over-year.
- BIOMERICA INC stock issued during period, value, stock options exercised for fiscal 2025 was $15.00K.
- BIOMERICA INC stock issued during period, value, stock options exercised for fiscal 2023 was $81.00K, a 5.19% increase from fiscal 2022.
- BIOMERICA INC stock issued during period, value, stock options exercised for fiscal 2022 was $77.00K, a 24.70% decline from fiscal 2021.
- BIOMERICA INC stock issued during period, value, stock options exercised for fiscal 2021 was $102.25K, a 54.26% decline from fiscal 2020.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2025-05-31 | $15.00K 10-K · filed 2026-08-31 | |
| 2025-02-28 | $16.00K 10-Q · filed 2026-04-13 | |
| 2023-05-31 | $81.00K 10-K · filed 2024-08-28 | |
| 2022-11-30 | $66.00K 10-Q · filed 2024-04-12 | $122.52K derived: sum of 4 quarters · filed 2024-04-12 |
| 2022-08-31 | $14.00K 10-Q · filed 2024-04-12 | $87.11K derived: sum of 4 quarters · filed 2024-04-12 |
| 2022-05-31 | $37.83K derived: 10-K 12 month − 10-Q 9 month · filed 2023-08-25 | $77.00K 10-K · filed 2023-08-25 |
| 2022-02-28 | $4.70K 10-Q · filed 2023-04-14 | $44.98K derived: sum of 4 quarters · filed 2023-04-14 |
| 2021-11-30 | $30.59K 10-Q · filed 2023-04-14 | $87.41K derived: sum of 4 quarters · filed 2023-04-14 |
| 2021-08-31 | $3.90K 10-Q · filed 2023-04-14 | $91.25K derived: sum of 4 quarters · filed 2023-04-14 |
| 2021-05-31 | $5.80K derived: 10-K 12 month − 10-Q 9 month · filed 2022-08-29 | $102.25K 10-K · filed 2022-08-29 |
| 2021-02-28 | $47.13K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-04-14 | $240.16K derived: sum of 4 quarters · filed 2022-04-14 |
| 2020-11-30 | $34.43K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-01-12 | $223.94K derived: sum of 4 quarters · filed 2022-01-12 |
| 2020-08-31 | $14.90K 10-Q · filed 2021-10-14 | $204.41K derived: sum of 4 quarters · filed 2021-10-14 |
| 2020-05-31 | $143.71K derived: 10-K/A 12 month − 10-Q 9 month · filed 2021-10-14 | $223.53K 10-K/A · filed 2021-10-14 |
| 2020-02-29 | $30.90K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-04-14 | $118.63K derived: sum of 4 quarters · filed 2021-04-14 |
| 2019-11-30 | $14.90K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-01-14 | |
| 2019-08-31 | $34.03K 10-Q · filed 2019-10-15 | |
| 2019-05-31 | $38.80K derived: 10-K 12 month − 10-Q 9 month · filed 2020-08-31 | $121.79K 10-K · filed 2020-08-31 |
| 2018-05-31 | $27.44K 10-K · filed 2019-08-29 | |
| 2017-05-31 | $157.73K 10-K · filed 2018-08-29 | |
| 2016-05-31 | $109.94K 10-K · filed 2017-08-29 | |
| 2015-05-31 | $9.56K 10-K · filed 2016-08-29 | |
| 2014-05-31 | $35.27K 10-K · filed 2015-08-31 | |
| 2013-05-31 | $51.51K 10-K · filed 2014-08-29 | |
| 2012-05-31 | $47.79K 10-K · filed 2013-08-29 | |
| 2011-05-31 | $83.00K 10-K · filed 2012-08-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |